Skip to main content Accessibility help
×
Home
Hostname: page-component-544b6db54f-5rlvm Total loading time: 0.158 Render date: 2021-10-19T09:10:11.491Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "metricsAbstractViews": false, "figures": true, "newCiteModal": false, "newCitedByModal": true, "newEcommerce": true, "newUsageEvents": true }

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa

Published online by Cambridge University Press:  02 January 2015

Erico A.G. Arruda
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Ivan S. Marinho
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Marcos Boulos
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Sumiko I. Sinto
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Helio H. Caiaffa F
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Caio M. Mendes
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Carmen P. Oplustil
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
Helio Sader
Affiliation:
Federal University of São Paulo, São Paulo, Brazil
Carlos E. Levy
Affiliation:
University of São Paulo, Ribeirāo Preto, Brazil
Anna S. Levin*
Affiliation:
Hospital Infection Control Department, Hospital das Clinicas, University of São Paulo, Brazil
*
Rua Harmonia, 564/52, São Paulo - SP 05435-000, Brazil

Abstract

A case-control study was done to evaluate factors associated with nosocomial infections by multiresistant Pseudomonas aeruginosa (MRPA). Results showed that MRPA was associated with the use of immunosuppressive and antimicrobial drugs. Five typing methods indicated that the MRPA infections were due to multiple strains rather than a single strain.

Type
Concise Communications
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Gaynes, PR, Culver, DH. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:1014.CrossRefGoogle ScholarPubMed
2. Garner, JS, Jarvis, WR, Emori, TG. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128140.CrossRefGoogle ScholarPubMed
3. Knaus, WA, Draper, EA, Wagner, DP, Zimmerman, JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818829.CrossRefGoogle ScholarPubMed
4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved standards. 1990;M2T4. Abstract.Google Scholar
5. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved standards. 1990;M7A2. Abstract.Google Scholar
6. Tenover, FC. Plasmid fingerprint of gram-negative organisms. In Isenberg, HD, ed. Clinical Microbiology Procedures Handbook. Washington, DC: ASM; 1992.Google Scholar
7. Kunin, CM. Resistance to antimicrobial drugs—a worldwide calamity. Ann Intern Med 1993;118:557561.CrossRefGoogle ScholarPubMed
8. McGowan, JE Jr. Antibiotic-resistant bacteria and healthcare system: four steps for effective response. Infect Control Hosp Epidemiol 1995;16:6770.CrossRefGoogle ScholarPubMed
9. Krcmery, V Jr, Trup, J, Kunova, A, Spanik, S, Drgona, L, Oravcova, E, et al. Imipenem-resistant Pseudomonas aeruginosa bacteraemia in cancer patients: risk factors, clinical features and outcome. Int J Clin Pharmacol Res 1996;16:4349.Google ScholarPubMed
10. Döring, G, Hörz, M, Ortelt, J, Grupp, H, Wolz, C. Molecular epidemiology of Pseudomonas aeruginosa in an intensive care unit. Epidemiol Infect 1993;110:427436.CrossRefGoogle Scholar
47
Cited by

Send article to Kindle

To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa
Available formats
×

Send article to Dropbox

To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa
Available formats
×

Send article to Google Drive

To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

Nosocomial Infections Caused by Multiresistant Pseudomonas aeruginosa
Available formats
×
×

Reply to: Submit a response

Please enter your response.

Your details

Please enter a valid email address.

Conflicting interests

Do you have any conflicting interests? *